Our Leadership - Cambridge Epigenetix

About Cambridge Epigenetix

Who We Are

CEGX develops products for academia and industry, democratizing step-changes in accuracy and cost.

Leadership Team

Peter Fromen Chief Executive Officer

Dr. Joanna Holbrook Chief Scientific Officer

Fiona Stewart Chief Financial Officer

Manuela Morgan Head of People

Dr. Philippa Burns Director of Research & Development

Dr. Páidí Creed Director of AI, Bioinformatics and Software

Dr. Tom Charlesworth Director Portfolio Strategy

Scientific Advisors

Prof. Sir Shankar Balasubramanian FRS Founder

Professor Wolf Reik Head of the Epigenetics Programme, Babraham Institute

Professor Anjana Rao Head of the Division of Signalling and Gene Expression, La Jolla Institute

Professor Mark Dawson Group Leader of the Cancer Epigenetics Laboratory, Peter MacCallum Cancer Centre

Board

Gail Marcus Chair of the Board

Dr. Bobby Yerramilli-Rao Co-Founder

Prof. Sir Shankar Balasubramanian FRS Co-Founder

Peter Fromen Chief Executive Officer

Tom Hulme General Partner, GV

Alice Newcombe-Ellis Managing Partner, Ahren Innovation Capital

Somu Subramaniam Managing Partner, New Science Ventures

Board Observers

Roelof F. Botha Managing Partner, Sequoia Capital

Ethan Park Director, Temasek

Anthony Philippakis Venture Partner, Google Ventures

Our Investors

Since its founding, Cambridge Epigenetix has been successful in creating value from innovation

We are creating a technology platform that will deliver a step change in the type of information that can be generated from DNA and the accuracy at which it can be generated. We expect our technology to become a fundamental component of healthcare and life sciences research.

Join Our Team

We have exciting opportunities to develop your career within a fast-paced and rapidly evolving biotech, with opportunities for individuals to grow with the company. We welcome applications from candidates interested in technical, leadership and individual contributor roles.